On June 7, 2024, Biora Therapeutics, Inc. announced that it held its annual general meeting of shareholders on June 5, 2024, and declared the voting results. As no further information has been discussed between the company and Athyrium Capital Management, LP, the campaign is considered to have been withdrawn.